In recent years, with the exception of 2022, growth stocks have led the way. However, over a longer period of time, dividend-paying stocks have offered higher returns. Read More
Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.
Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.
Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.
Analyst Articles
Psychedelics once demonized by polite society are now being deployed by the government and medical establishment to combat tobacco addiction. Read More
The latest economic data reflect disinflationary trends, strengthening the case for the Fed to sit pat on rates at its next meeting. Read More
This week I look back at a list of undervalued and overvalued stocks I picked in 2021 to see how they have performed since. Read More
This week, we cover Greyscale's big win against the SEC and what it means for a spot Bitcoin ETF. Plus, we take a trip to Argentina... Read More
With the Labor Day holiday upon us, now's a good time to examine common blunders that investors make with their retirement portfolios. Read More
Now that the seasonal transition from summer to fall is underway, let’s review the past month and look at the month ahead. Read More
For a relatively small sum of money, the private equity firm could immediately gain access to a high growth market. Read More
The latest data for the central bank’s preferred inflation gauge showed a slight uptick, but the long-term inflation trend remains favorable. Read More
Health and Human Services announced this week that it’s asking the Drug Enforcement Administration to move cannabis from Schedule I to Schedule III. Read More